A client who has polycystic kidney disease (PKD) presents to the emergency department with reports of a severe headache. Which of the following complications should the nurse expect?

Choice A reason: Aluminum hydroxide does not primarily lower serum calcium levels. Calcium levels are typically managed in CKD patients through other medications and dietary restrictions, as hypercalcemia can occur in these patients.

Choice B reason: Aluminum hydroxide acts as a phosphate binder, which helps to lower serum phosphorus levels in patients with CKD. This is important because high phosphorus levels can lead to bone and heart problems in these patients. The normal range for serum phosphorus is approximately 2.5 to 4.5 mg/dL.

Choice C reason: Aluminum hydroxide does not have a significant effect on serum potassium levels. In CKD, potassium levels are managed through diet and other medications due to the risk of hyperkalemia, which can be life- threatening.

Choice D reason: While magaldrate contains magnesium, which could potentially worsen hypermagnesemia in CKD patients, aluminum hydroxide does not lower serum magnesium levels. Instead, it is less likely to cause elevated magnesium levels compared to magaldrate.

Choice A reason: Diuretic use, especially thiazide diuretics, can lead to increased calcium in the urine, which is a risk

factor for the development of calcium stones.

Choice B reason: Hypocalcemia is not typically associated with an increased risk of urolithiasis. In fact, hypercalcemia can be a risk factor due to increased calcium excretion.

Choice C reason: A family history of kidney stones is a known risk factor for urolithiasis, as genetic factors can in?uence stone formation.

Choice D reason: A BMI less than 25 is generally not considered a risk factor for urolithiasis; higher BMI levels have been associated with an increased risk.